Genazzani AR - Search Results

1

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1997 Nov-Dec;17(6D):4463-6. Anticancer Res. 1997. PMID: 9494551

2

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.

Gadducci A, Cosio S, Tana R, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Crit Rev Oncol Hematol. 2009 Jan;69(1):12-27. doi: 10.1016/j.critrevonc.2008.05.001. Epub 2008 Jul 1. Crit Rev Oncol Hematol. 2009. PMID: 18595727 Review.

3

Intratumoral microvessel density, response to chemotherapy and clinical outcome of patients with advanced ovarian carcinoma.

Gadducci A, Viacava P, Cosio S, Fanelli G, Fanucchi A, Cecchetti D, Cristofani R, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 2003 Jan-Feb;23(1B):549-56. Anticancer Res. 2003. PMID: 12680144

4

The management of malignant nondysgerminomatous ovarian germ cell tumors.

Gadducci A, Cosio S, Muraca S, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 2003 Mar-Apr;23(2C):1827-36. Anticancer Res. 2003. PMID: 12820465 Review.

5

The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer.

Gadducci A, Marrai R, Baicchi U, Ferdeghini M, Fanucchi A, Facchini V, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1995 Nov-Dec;15(6B):2683-6. Anticancer Res. 1995. PMID: 8669847

6

Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.

Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Prato B, Prontera C, Facchini V, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1996 Sep-Oct;16(5B):3125-8. Anticancer Res. 1996. PMID: 8920779

7

Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer.

Gadducci A, Ferdeghini M, Buttitta F, Fanucchi A, Annicchiarico C, Prontera C, Bevilacqua G, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1996 Nov-Dec;16(6B):3519-23. Anticancer Res. 1996. PMID: 9042215

8

Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer.

Gadducci A, Marrai R, Baicchi U, Ferdeghini M, Fanucchi A, Weiss C, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Gynecol Oncol. 1997 Jul;66(1):85-8. doi: 10.1006/gyno.1997.4704. Gynecol Oncol. 1997. PMID: 9234926 Clinical Trial.

9

Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.

Gadducci A, Brunetti I, Cosio S, Giannessi PG, Genazzani AR, Conte P. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1997 Nov-Dec;17(6D):4703-8. Anticancer Res. 1997. PMID: 9494592 Review.

10

The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.

Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Fanucchi A, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: genazzani ar. Anticancer Res. 1998 Jan-Feb;18(1B):537-9. Anticancer Res. 1998. PMID: 9568174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

864 results

Search Page

Filters